Cafepharma Today

June 20 2025 - Gene therapy faces fresh uncertainty as two more top FDA officials depart
Gene therapy faces fresh uncertainty as two more top FDA officials depart
Eli Lilly (LLY) sees strong demand for Mounjaro in India
A longer ‘winter’: Public funding slowdown heightens pressure on biotech startups
Is DTC pharma advertising coming to an end?
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Illumina, CRISPR-pioneer Broad Institute to work on new gene sequencing kits
Reuters
Tuesday, August 13, 2024 - 11:01pm
tags:
Illumina, Medtech, Broad Institute, CRISPR, gene sequencing
The ‘Sledgehammer’ Approach to Recycling Medical Plastics
Medical Devices and Diagnostics Industry
Tuesday, August 13, 2024 - 10:59pm
tags:
recycling, Medtech, plastics, sustainability
Eli Lilly unwraps $700M nucleic acid R&D center in Boston Seaport, opens doors to biotechs
Fierce Biotech
Tuesday, August 13, 2024 - 11:49am
tags:
Eli Lilly, Boston, R&D, DNA, RNA
5 Obesity Readouts to Watch in the Second Half of 2024
BioSpace
Tuesday, August 13, 2024 - 11:47am
tags:
obesity, clinical trials, Novo Nordisk, CagriSema, Amgen, MariTide, Monlunabant, Aphaia Pharma, APHD-012, Terns Pharmaceuticals, TERN-601
Can Rite Aid Recover?
Drug Channels
Tuesday, August 13, 2024 - 11:41am
tags:
Rite Aid, pharmacies, bankruptcy
Enzo Biochem to pay $4.5 mln over cyberattack, NY attorney general says
Reuters
Tuesday, August 13, 2024 - 11:40am
tags:
Enzo Biochem, New York, cyberattack, cybersecurity
J&J has enough support for $6.5 bln talc settlement
Yahoo/Reuters
Tuesday, August 13, 2024 - 11:38am
tags:
JNJ, legal, bankruptcy
Sluggish enrollment leads Boundless Bio to make 'modest' layoffs 5 months after $100M IPO
Fierce Biotech
Tuesday, August 13, 2024 - 11:32am
tags:
Boundless Bio, layoffs, clinical trials, IPOs, BBI-355
Carlyle to buy Baxter's kidney-care spinoff Vantive for $3.8 billion
Reuters
Tuesday, August 13, 2024 - 11:29am
tags:
Carlyle Group, Baxter, M&A, Vantive, Medtech
A potential MS ‘game changer’ could bring more safety to the table — even against viruses
Pharma Voice
Tuesday, August 13, 2024 - 11:28am
tags:
Immunic, vidofludimus calcium, MS, multiple sclerosis
Galderma gets FDA nod for prurigo nodularis therapy
Pharmaphorum
Tuesday, August 13, 2024 - 11:26am
tags:
Galderma, FDA, Nemluvio, prurigo nodularis
Skyrizi soars to top of Rx, OTC pharma brand rankings in July
Medical Marketing and Media
Tuesday, August 13, 2024 - 11:25am
tags:
Skyrizi, AbbVie, television ads
Novo Nordisk plots 2024 FDA filing for once-weekly insulin and semaglutide combo
Fierce Pharma
Monday, August 12, 2024 - 6:01pm
tags:
Novo Nordisk, FDA, insulin, semaglutide, Icosema
Novartis loses initial bid to block generic of best-selling heart drug
Reuters
Monday, August 12, 2024 - 5:57pm
tags:
Novartis, legal, MSN Pharmaceuticals, Entresto, heart failure, generics
UCB leads pharma in CX, according to DT Consulting survey
Medical Marketing and Media
Monday, August 12, 2024 - 5:56pm
tags:
UCB Pharma, Customer Experience, physicians, HCPs
Senseonics Looks to Stand Apart from the Big 3 in Diabetes Tech
Medical Devices and Diagnostics Industry
Monday, August 12, 2024 - 5:54pm
tags:
Medtech, Senseonics, continuous glucose monitoring, Eversense, diabetes, CGMs
5 things to know ahead of the Medicare drug price announcement
Beckers Hospital Review
Monday, August 12, 2024 - 5:53pm
tags:
Medicare, Inflation Reduction Act, drug pricing, CMS
Novartis' Complement Inhibitor Fabhalta Approved for IgAN
Contract Pharma
Monday, August 12, 2024 - 5:52pm
tags:
FDA, Novartis, Fabhalta, primary IgA nephropathy
Pfizer, looking to expand RSV vaccine's reach, touts its benefits in immunocompromised adults
Fierce Pharma
Monday, August 12, 2024 - 11:42am
tags:
Pfizer, RSV, vaccines, Abrysvo, immunocompromised patients
Revance Therapeutics shares soar on takeover by Crown Labs
Markewatch
Monday, August 12, 2024 - 11:41am
tags:
Revance Therapeutics, Crown Laboratories, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.